A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors.
Allergy Asthma Proc
; 43(6): 471-473, 2022 Nov 01.
Article
in English
| MEDLINE | ID: covidwho-2154574
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Urticaria
/
Biological Products
/
Dermatitis, Atopic
/
Eosinophilia
/
Janus Kinase Inhibitors
/
Chronic Urticaria
/
Lung Diseases
Limits:
Humans
Language:
English
Journal:
Allergy Asthma Proc
Journal subject:
Allergy and Immunology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS